Big chunk of ad revenue and time spent unlocked with TikTok ban, says Roth MKM's Rohit Kulkarni
Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...
Roth calls ‘Narnia’ deal with Netflix ‘significant’ for Imax
Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...
bovnews18h
ROTH MKM Issues Buy Rating for Reviva Pharmaceuticals Holdings Inc (RVPH) Stock
Stock Trading Recap. On Friday, Reviva Pharmaceuticals Holdings Inc (RVPH) stock saw a decline, ending the day at $1.77 which represents ...
Roth MKM Internet/capital markets analyst holds analyst/industry conference call
Internet & Capital Markets Analyst Kulkarni, along with Udayan Bose, CEO of NetElixir, Alan Chapell, President of Chapell & Associates ...
Roth MKM Keeps Their Buy Rating on Plug Power (PLUG)
In a report released today, Craig Irwin from Roth MKM maintained a Buy rating on Plug Power (PLUG – Research Report), with a price target of ...
Truist Financial Raises Target (NYSE:TGT) Price Target to $134.00
Target (NYSE:TGT – Get Free Report) had its price target upped by stock analysts at Truist Financial from $129.00 to $134.00 ...
Mattel price target lowered to $20 from $21 at Roth MKM
Roth MKM lowered the firm’s price target on Mattel (MAT) to $20 from $21 and keeps a Neutral rating on the shares ahead of ...
Assenagon Asset Management S.A. Has $9.02 Million Stake in The Boston Beer Company, Inc. (NYSE:SAM)
Assenagon Asset Management S.A. decreased its position in The Boston Beer Company, Inc. (NYSE:SAM – Free Report) by 19.5% ...
bovnews19h
Why Did Atkore Inc (ATKR) Stock See -4.29% Plunge in the Last 90 Days?
Atkore Inc (ATKR) stock saw a modest uptick, ending the day at $85.17 which represents a slight increase of $1.72 or 2.06% from the prior close of $83.45. The stock opened at $84.61 and touched a low ...
Nasdaq1mon
Roth MKM ‘cautiously optimistic’ on Digi International in FY26
Roth MKM keeps a Buy rating and $38 price target on Digi International (DGII) following its non-deal roadshow with the management team. The firm comes away from the discussions “cautiously ...
Nasdaq1mon
Roth MKM starts ‘overlooked’ Entrada Therapeutics with Buy rating
Roth MKM last night initiated coverage of Entrada Therapeutics (TRDA) with a Buy rating and $29 price target Entrada is an early-stage biopharma that seeks to solve a key bottleneck, which is ...